https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.880887/full
Macrophages are paracrine signalers that regulate tissular responses to injury through interactions with parenchymal cells. Connexin hemichannels have recent...
frontiersmacrophagenecessaryfibroblastcytosolic
https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-fibrosis/resource-library
Learn all you can about pulmonary fibrosis. View videos, downloadable PDFs, a glossary of terms and continuing education for healthcare professionals.
american lung associationpulmonary fibrosisresource library
https://pubmed.ncbi.nlm.nih.gov/15532079/
Recombinant DNase (dornase alpha) was shown to improve lung function and reduce pulmonary exacerbations in cystic fibrosis (CF) patients, but its effects on...
cystic fibrosisdnaconcentrationsbalfluid
https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-fibrosis/resource-library/glossary-of-terms
Learn all you can about pulmonary fibrosis. View videos, downloadable PDFs, a glossary of terms and continuing education for healthcare professionals.
american lung associationpulmonary fibrosisglossary
https://www.lung.org/lung-health-diseases/lung-disease-lookup/cystic-fibrosis
Cystic fibrosis (CF) is an inherited disease that causes thickened mucus to form in the lungs, pancreas and other organs. In the lungs, this mucus blocks the...
american lung associationcystic fibrosiscf
https://www.prnewswire.com/news-releases/aqualung-therapeutics-receives-fda-clearance-for-phase-2a-lung-fibrosis-study-302648010.html
/PRNewswire/ -- Aqualung Therapeutics, a clinical-stage immunotherapeutics company, announced today that the Food and Drug Administration (FDA) has cleared...
lung fibrosisaqualungtherapeuticsreceivesfda